Summary
The possibility of a pharmacokinetic interaction between amitriptyline and toloxatone (a new MAOI-A) has been studied in 17 depressed in-patients.
Amitriptyline and its demethylated and hydroxylated metabolites in blood and urine were measured at steady state after the administration of amitriptyline with and without toloxatone in steady state. The metabolic status of patients was determined using the dextromethorphan phenotyping test.
There was only a minor pharmacokinetic interaction between amitriptyline (AMT) and toloxatone, with a small increase in the AMT/NT (nortriptyline) plasma ratio: 0.68 before and 0.78 after toloxatone. The urinary excretion and plasma levels of AMT and its metabolites were not affected by the co-therapy.
Three of the patients were poor metabolisers, but this did not predict the magnitude of the drug interaction.
The interaction does not justify plasma level monitoring of amitriptyline as the change in pharmacokinetics was so small.
This is a preview of subscription content, log in via an institution to check access.
References
Goldberg RS, Thornton WE (1978) Combined tricyclic-MAOI therapy for refractory depression: a review, with guidelines for appropriate usage. J Clin Pharmacology 18: 143–147
Blackwell B (1991) Monoamine oxidase inhibitor interactions with other drugs. J Clin Psychopharmacol 11: 55–59
Ho BT (1972) Monoamine oxidase inhibitors. J Pharm Sci 61: 821
Sullivan JL, Dackis C, Stanfield C (1977) In vivo inhibition of platelet MAO activity by tricyclic antidepressants. Am J Psychiat 134: 188–190
Simpson GM, De Leon J (1989) Tyramine and new monoamine oxidase inhibitor drugs. Br J Psychiat 155: 32–37
Rovei V, Vajta S, Le Moing JP, Strolin Benedetti M (1983) Metabolism of toloxatone in man. Encéphale IX [Suppl 1]: 92A
Vandel S, Sandoz M, Vandel B, Bonin B, Allers G, Volmat R (1986) Biotransformation of amitriptyline in man: interaction with phenothiazines. Neuropsychobiol 15: 15–19
Gram LF, Overo KF, Kirk L (1974) Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man. Am J Psychiatry 131: 863–866
Perault MC, Bouquet S, Bertschy G, Vandel S, Chakroun R, Guibert S, Vandel B (1991) Phenotype d'oxydation de la débrisoquine et du dextomethorphane au cours de traitements anti-dépresseurs. Thérapie 46: 1–3
Vandel B, Vandel S, Jounet JM, Allers G, Volmat R (1982) Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and clinical response. Eur J Clin Pharmacol 22: 15–20
Vajta S, Le Moing JP, Rovei V (1983) Gas liquid chromatographic determination of toloxatone in human plasma. J Chromatogr 274: 139–148
East T, Dye D (1985) Determination of dextromethorphan and metabolites in human plasma and urine by hight-performance liquid chromatography with fluorescence detection. J Chromatogr 338: 99–112
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vandel, S., Bertschy, G., Perault, M.C. et al. Minor and clinically non-significant interaction between toloxatone and amitriptyline. Eur J Clin Pharmacol 44, 97–99 (1993). https://doi.org/10.1007/BF00315289
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315289